Evidence map›Paper›PMID 28276505›Full record

ArticleScientific reports2017

Alternative exon skipping biases substrate preference of the deubiquitylase USP15 for mysterin/RNF213, the moyamoya disease susceptibility factor.

Yuri Kotani, Daisuke Morito, Kenshiro Sakata, Shiori Ainuki, Munechika Sugihara, Tomohisa Hatta, Shun-Ichiro Iemura, Seiji Takashima, Tohru Natsume, Kazuhiro Nagata

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. The Multifaceted Roles of USP15 in Signal Transduction.International journal of molecular sciences · 2021
    Review
  6. Article
  7. The ring finger protein 213 gene (Rnf213) contributes to Rift Valley fever resistance in mice.Mammalian genome : official journal of the International Mammalian Genome Society · 2021
    Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Yuri KotaniFaculty of Life Sciences, Kyoto Sangyo University, 603-8555, Japan.
Daisuke MoritoInstitute for Protein Dynamics, Kyoto Sangyo University, 603-8555, Japan.
Kenshiro SakataFaculty of Life Sciences, Kyoto Sangyo University, 603-8555, Japan.
Shiori AinukiFaculty of Life Sciences, Kyoto Sangyo University, 603-8555, Japan.
Munechika SugiharaFaculty of Life Sciences, Kyoto Sangyo University, 603-8555, Japan.
Tomohisa HattaBiomedicinal Information Research Center, National Institute of Advanced Industrial Science and Technology, 135-0064, Japan.
Shun-Ichiro IemuraBiomedicinal Information Research Center, National Institute of Advanced Industrial Science and Technology, 135-0064, Japan.
Seiji TakashimaGraduate School of Medicine, Osaka University, 565-0871, Japan.
Tohru NatsumeBiomedicinal Information Research Center, National Institute of Advanced Industrial Science and Technology, 135-0064, Japan.
Kazuhiro NagataFaculty of Life Sciences, Kyoto Sangyo University, 603-8555, Japan.
Kyoto Sangyo University · JPNational Institute of Advanced Industrial Science and Technology · JPJapan Science and Technology Agency · JPOsaka University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The deubiquitylating enzyme USP15 plays significant roles in multiple cellular pathways including TGF-β signaling, RNA splicing, and innate immunity. Evolutionarily conserved skipping of exon 7 occurs during transcription of the mRNAs encoding USP15 and its paralogue USP4, yielding two major isoforms for each gene. Exon 7 of USP15 encodes a serine-rich stretch of 29 amino acid residues located in the inter-region linker that connects the N-terminal putative regulatory region and the C-terminal enzymatic region. Previous findings suggested that the variation in the linker region leads to functional differences between the isoforms of the two deubiquitylating enzymes, but to date no direct evidence regarding such functional divergence has been published. We found that the long isoform of USP15 predominantly recognizes and deubiquitylates mysterin, a large ubiquitin ligase associated with the onset of moyamoya disease. This observation represents the first experimental evidence that the conserved exon skipping alters the substrate specificity of this class of deubiquitylating enzymes. In addition, we found that the interactomes of the short and long isoforms of USP15 only partially overlapped. Thus, USP15, a key gene in multiple cellular processes, generates two functionally different isoforms via evolutionarily conserved exon skipping.

Indexed as

Genetic Predisposition to DiseaseAdenosine TriphosphatasesAlternative SplicingExonsHEK293 CellsHumansIsoenzymesMoyamoya DiseaseProtein BindingSubstrate SpecificityUbiquitinationUbiquitin-Protein LigasesUbiquitin-Specific ProteasesAdenosine TriphosphatasesIsoenzymesRNF213 protein, humanUbiquitin-Protein LigasesUbiquitin-Specific ProteasesUSP15 protein, human

Identifiers

PMID28276505
PMCPMC5343593
OpenAlexW2592225665

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.